Investors Flock to Biotech March 03, 2014 | Press Release
Biotech IPOs Off to a Strong Start in 2014 February 03, 2014 | Press Release
Idea to IPO - Transitions in Healthcare 2014 January 29, 2014 | Press ReleaseSee all News
Burrill executive cited among 25 people worth knowing in bioenergySeptember 14, 2010
SAN FRANCISCO – Burrill & Company is pleased to announce that the publication Biofuels Digest* has cited Dr. John Hamer among the 25 people worth knowing in an article profiling speakers who will be presenting at the Advanced Biofuels Markets conference, November 9-10, 2010 in San Francisco.
The Editor of Biofuels Digest,
“I am delighted that Dr. Hamer has been recognized by Biofuels Digest,” said G. Steven Burrill, CEO, Burrill & Company, a San Francisco based global leader in life sciences with activities in private equity, venture capital, merchant banking and media. “He is an integral part of our Venture Capital team, which has made significant investments in the bioenergy sector. Burrill & Company is proud to be known as one of the investment leaders in this world critical industry.
“We have been investing in ag- and industrial biotechnology for over a decade now and are continuing to build upon our expertise as we see tremendous ongoing investment opportunities in the biogreentech sector,” Burrill added.
Dr. Hamer joined Burrill & Company in November 2003 as Entrepreneur-In-Residence and became a Managing Director in 2006. Prior to joining Burrill & Company, Dr. Hamer helped to build Paradigm Genetics/Icoria (acquired by Clinical Data, CLDA: NASDAQ) from its beginning in 1998, serving in various capacities as Director of Microbial Research, Vice President of Research, Chief Scientific Officer, Vice President for Business Development, and Interim President and CEO. He received his Ph.D. in Microbiology from the
In addition, Dr. Hamer has been a regular presenter at the Advanced Biofuels Leadership Conference and will be a panelist on a session entitled “Financing Advanced Biofuels: Strategies, Players and Structures” at the upcoming Advanced Biofuels Markets conference.
About Burrill & Company
Founded in 1994, Burrill & Company is a San Francisco-based global leader in life sciences with activities in Venture Capital, Private Equity, Merchant Banking and Media. The Burrill family of venture capital funds has over $1 billion under management and its merchant banking business is one of the industry leaders assisting life science companies to identify, negotiate and close strategic transactions. Burrill is also the creator, sponsor and facilitator of leading industry conferences worldwide and publisher of a range of bio-intelligence reports including the monthly Burrill Report (www.burrillreport.com) and annual “State of the Industry” report, the latest of which is entitled Biotech 2010-Life Sciences: Adapting for Success.
Contact: Peter Winter, Managing Director, Editorial, Burrill & Company & Editor, Burrill Report (email@example.com) Tel: 415-591-5474
Back to News list